Delivery Order SPE2DE24D0013-SPE2D625F9Z7J

The U.S. Defense-affiliated Medical Supply Chain awarded a $8,160 firm fixed-price delivery order to Cepheid Inc. on May 30, 2025, with an ultimate completion date of June 6, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic systems, specializes in point-of-care testing technologies and reagents for infectious disease detection. The contract carries no set-aside designation and reflects standard competitive procurement practices. The place of performance is located in Sunnyvale, CA.

This delivery order likely derives from one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Veterans Administration, which provide the framework for ongoing procurement of molecular diagnostic reagents and assays. Cepheid maintains two significant IDV agreements with VA networks—a $32.8 million contract with Veterans Integrated Service Network 6 extending through September 2030 and a $2.5 million contract with Veterans Integrated Service Network 21 for PCR testing covering respiratory and laboratory microbiology diagnostics. The company has established itself as a key federal supplier of GeneXpert diagnostic systems and related testing services across multiple VA networks and Defense Logistics Agency programs, delivering integrated solutions for infectious disease identification in federal healthcare settings.